The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models.

Shelke, Abhay R; Mustian, Karen M; Morrow, Gary R.
Indian J Physiol Pharmacol ; 2004 Jul; 48(3): 256-68
Artículo en Inglés | IMSEAR | ID: sea-107729

Documentos relacionados

  1. Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy-induced nausea and vomiting management: Experiences at an academic medical center.
  2. [Chemotherapy-induced nausea and vomiting].
  3. A Scoping Review of Biological Pathways of Integrative Interventions Used to Manage Chemotherapy-Induced Nausea and Vomiting in Children With Cancer.
  4. Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
  5. Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)-a systematic review and individual patient data meta-analysis.
  6. 2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
  7. The Effect of Concealing the Hydration Fluid on Anticipatory Nausea-Vomiting in Pediatric Hematology-Oncology Patients Undergoing Chemotherapy Treatment: A Randomized Controlled Study.
  8. [China guidelines on prevention and treatment of nausea and vomiting caused by antitumor therapies (2023 edition)].
  9. Efficacy and Safety of Olanzapine for the Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
  10. Determining the factors affecting chemotherapy-induced nausea and vomiting in children with cancer.